TherapeuticsMD, Inc.
TXMD
$1.17
-$0.03-2.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.10M | -2.18M | -3.32M | -6.09M | -7.41M |
| Total Depreciation and Amortization | 471.00K | 509.00K | 562.50K | 595.50K | 544.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 551.00K | 744.00K | -2.01M | 4.19M | 2.31M |
| Change in Net Operating Assets | 2.49M | 1.66M | -2.36M | -8.09M | -10.40M |
| Cash from Operations | 1.41M | 732.00K | -7.12M | -9.39M | -14.96M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 2.00M | 2.00M | 3.15M |
| Repurchase of Common Stock | -- | -- | -- | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -1.11M | -1.11M |
| Cash from Financing | -- | -- | 2.00M | 894.00K | 2.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.41M | 732.00K | -5.12M | -8.50M | -12.91M |